BACKGROUND. Androgen-independent growth leads to progressive prostate cancer after androgen-ablation therapy. This may be caused by altered specificity of the androgen receptor (AR), by ligand-independent stimulation of the AR, or by paracrine growth modulation by neuropeptides secreted by neuroendo
Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status
β Scribed by Serafin, Antonio ;Akudugu, John ;Bohm, Lothar
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 259 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell
## Abstract __RAD51D__, a paralog of the mammalian __RAD51__ gene, contributes towards maintaining genomic integrity by homologous recombination DNA repair and telomere maintenance. A __RAD51D__ variant, E233G, was initially identified as a potential susceptibility allele in highβrisk, siteβspecifi
BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-β€-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell